Want to see GB:SPI full AI Analyst Report?
SPI Stock Chart & Stats
169.00 p
0.50 p(0.22%)
At close: 4:00 PM EST
169.00 p
0.50 p(0.22%)
Day’s Range― - ―
52-Week Range140.80 p - 256.50 p
Previous CloseN/A
Volume20.07K
Average Volume (3M)1.66M
Market Cap
£851.02M
Enterprise Value2.15B
Total Cash (Recent Filing)£34.70M
Total Debt (Recent Filing)£1.32B
Price to Earnings (P/E)51.7
Beta0.61
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.37%
Share Statistics
EPS (TTM)0.04
Shares Outstanding402,759,600
10 Day Avg. Volume559,423
30 Day Avg. Volume1,661,785
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)0.90
Price to Sales (P/S)0.42
P/FCF Ratio4.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£260.00Price Target Upside53.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.08
Revenue Forecast (FY)£1.61B
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Demand RecoveryMaterial top-line recovery from £0.92bn to £1.58bn since 2020 indicates durable demand for elective and diagnostic services. Higher volumes and scale across hospitals support utilization, referral networks and pricing negotiating leverage with insurers and the NHS over the medium term.
Consistent Cash GenerationSustained positive operating cash flow and meaningful free cash flow provide structural capacity to service debt, fund maintenance capex and support reinvestment in sites. Consistent cash conversion underpins financial resilience even if margins vary, enabling medium-term strategic flexibility.
Stable Operating MarginsRelatively steady operating margins in the high single digits and mid-teens EBITDA imply an established cost base and scalable hospital model. This stability supports predictable operating cash flows and suggests management can sustain operating profitability across the estate.
Bears Say
High LeverageDebt materially exceeds equity, leaving limited balance-sheet cushion. Elevated leverage increases refinancing and interest-rate sensitivity, restricts strategic optionality for M&A or capex, and magnifies downside risk if operating cash flow weakens over the medium term.
Very Thin Net MarginsNet margins near 1% mean limited earnings buffer after interest and tax. With thin bottom-line conversion, small revenue or cost shocks—or higher financing costs—can quickly depress reported earnings and returns on equity, constraining capacity to rebuild reserves.
Moderate Cash Coverage & FCF ConversionFree cash flow is positive but only ~65% of net income and historical coverage ratios under 0.7 imply limited headroom to absorb shocks. This constrains discretionary spending, dividend growth and rapid deleveraging if activity or reimbursement rates deteriorate.
Spire Healthcare News
SPI FAQ
What was Spire Healthcare Group PLC’s price range in the past 12 months?
Spire Healthcare Group PLC lowest share price was 140.80 p and its highest was 256.50 p in the past 12 months.
What is Spire Healthcare Group PLC’s market cap?
Spire Healthcare Group PLC’s market cap is £851.02M.
When is Spire Healthcare Group PLC’s upcoming earnings report date?
Spire Healthcare Group PLC’s upcoming earnings report date is Sep 10, 2026 which is in 62 days.
How were Spire Healthcare Group PLC’s earnings last quarter?
Spire Healthcare Group PLC released its earnings results on Mar 05, 2026. The company reported 0.025 p earnings per share for the quarter, missing the consensus estimate of 0.05 p by -0.025 p.
Is Spire Healthcare Group PLC overvalued?
According to Wall Street analysts Spire Healthcare Group PLC’s price is currently Undervalued.
Does Spire Healthcare Group PLC pay dividends?
Spire Healthcare Group PLC pays a Annually dividend of 1.5 p which represents an annual dividend yield of 1.37%. See more information on Spire Healthcare Group PLC dividends here
What is Spire Healthcare Group PLC’s EPS estimate?
Spire Healthcare Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spire Healthcare Group PLC have?
Spire Healthcare Group PLC has 402,759,600 shares outstanding.
What happened to Spire Healthcare Group PLC’s price movement after its last earnings report?
Spire Healthcare Group PLC reported an EPS of 0.025 p in its last earnings report, missing expectations of 0.05 p. Following the earnings report the stock price went down -2.464%.
Which hedge fund is a major shareholder of Spire Healthcare Group PLC?
Currently, no hedge funds are holding shares in GB:SPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Spire Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.10%
12-Months-Change
Fundamentals
Return on Equity
2.22%
Trailing 12-Months
Asset Growth
1.45%
Trailing 12-Months
Company Description
Spire Healthcare Group PLC
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
SPI Stock 12 Month Forecast
Average Price Target
260.00 p
▲(53.85% Upside)
Technical Analysis
Allergy Therapeutics
―
Circassia Pharmaceuticals
―
Craneware
―
PureTech Health
―
Optima Health PLC
―
Options Prices
Currently, No data available
---